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A B S T R A C T
Chronic psychosocial stress at workplace is an important factor in the development of physical and mental
illness. Objective biological measures of chronic stress are still lacking, but inﬂammatory response and growth
factors are increasingly considered as potential stress biomarkers. Therefore, we investigated the relationship
between psychophysical strain and serum levels of 48 chemokines, cytokines and growth factors measured using
a multiplex immunoassay, and serum brain-derived neurotrophic factor (BDNF) measured by ELISA. Severity of
psychophysical strain was scored in 115 healthy hospital workers using speciﬁc scales for anxiety, depression-
like emotion, gastrointestinal or cardiac disturbances, and ergonomic dysfunction. Multivariate analysis revealed
that higher anxiety scale scores were correlated with lower serum chemokine C-C motif ligand-2 (CCL2/MCP-1),
chemokine C-C motif ligand-5 (CCL5/RANTES), chemokine C-C motif ligand-27 (CCL27/CTACK), chemokine C-
C motif ligand-11 (CCL11/Eotaxin) and interleukin-6 (IL-6); gastrointestinal disturbances correlated with in-
creased levels of interleukin-17 (IL-17) and reduced CCL11/Eotaxin, CCL27/CTACK and CCL2/MCP-1; while
cardiac dysfunctions associate only to reduced CCL27/CTACK, and ergonomic dysfunction correlated with in-
creased BDNF and reduced CCL11/Eotaxin and CCL5/RANTES. Thus, these 7 serum factors may provide a
distinct signature for each diﬀerent stress-related psychophysical outcome giving indications on individual
vulnerabilities.
1. Introduction
Real or perceived threats at job (i.e. stressors) can activate a net-
work of behavioral, psychological and physical reactions in the in-
dividual (i.e. psychophysical strain), collectively known as work-related
stress (Girardi et al., 2015). This chronic stress condition is a process
that occurs when a person has or feels a high job demand having
however low job control, thus feeling unable to cope with the requests
(de Jonge et al., 2010). Another means driving this kind of chronic
stress is the alteration in the eﬀort-reward balance (Siegrist et al.,
2004), in terms of salary, accomplishment or job perspectives in front of
demanding tasks. Work-related chronic stress is an emerging factor in
the development of physical and mental illness (such as depression) and
many people experience physical and psychological symptoms related
to stress (Ganster and Rosen, 2013; Nixon et al., 2011). Accordingly,
psychophysical strain is associated with increased sickness absences
and reduced job performance (Falco et al., 2013a, 2013b).
The pathophysiological events triggered by prolonged exposure to
stress in humans are not completely characterized, but they involve the
hypothalamus-pituitary-adrenal (HPA) axis involving stress hormones
such as corticotropin-releasing hormone (CRH), adrenocorticotropic
hormone (ACTH) and glucocorticoids, the sympathetic-adrenal-medul-
lary (SAM) axis as well as the endocrine system (Chandola et al., 2010;
Dhabhar, 2014; Juster et al., 2010). Besides the above mentioned me-
chanisms, the recognition that immune alteration is a primary patho-
physiological mechanism in chronic stress is one of the major scientiﬁc
insights of the decade (Reiche et al., 2004; Schmidt et al., 2010;
Segerstrom and Miller, 2004; Dhabhar, 2014; Siegrist and Li, 2017).
Previous studies showed that sympathetic system stimulate in-
ﬂammatory cytokine production (McEwen et al., 2015) which in turn
augment glucocorticoid production, that has usually anti-inﬂammatory
eﬀects, but it can be also pro-inﬂammatory, in some cases (Munhoz
et al., 2010). Inﬂammation has been hypothesized to be a biomarker of
chronic psychophysiological stress, with interleukins 6 (IL-6),
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interferons (IFNs) and tumor necrosis factors (TNFs) as the most in-
vestigated candidates (Hansel et al., 2010). In addition, other studies
reported a general immune suppression (Calcagni and Elenkov, 2006;
Dhabhar et al., 2012), highlighting the complexity of interactions be-
tween brain and immune system. Chronic stress is known to increase
susceptibility to infection and cancer, due to immune suppression, but it
may also exacerbate allergic or autoimmune conditions involving a shift
in cytokine balance from type-1 to type-2 response, meaning a decrease
in cellular immunity in favour of a humoral immunity (Dhabhar, 2014;
Glaser et al., 2001). Moreover, the stress response includes alterations
in the levels of growth factors and neurotrophins, like the brain-derived
neurotrophic factor (BDNF) (Bath et al., 2013; Mitoma et al., 2008).
Indeed, decreased BDNF levels are associated with stress-related re-
duction in dendritic branching and spine density of CA3 neurons
(Davidson and McEwen, 2012).
Psychophysical strain is usually evaluated by the worker himself
(i.e., through self-report questionnaires) or by occupational physicians
with the aid of ad-hoc questionnaires, which allow quantitative as-
sessment of speciﬁc dimensions of psychophysical strain (Falco et al.,
2013a). However, in addition to the valuable function of these ques-
tionnaires, it would be very useful to include in the assessment also
objective biological measures, which are still lacking. In this study, we
tested the hypothesis that psychophysical strain may aﬀect blood levels
of cytokines, chemokines and growth factors, including BDNF and that
these relationships might be stronger in females than in males (Evolahti
et al., 2006). From a psychological standpoint, gender may inﬂuence in
several ways the stress process. For example, previous research has
shown that women, compared to men, may perceive work situations as
more stressful, engage more frequently in less adaptive coping strate-
gies (e.g., emotion-focused), and also experience higher levels of psy-
chophysical strain (Day and Livingstone, 2003; Eaton and Bradley,
2008; Tytherleigh et al., 2007). From a methodological point of view,
we examined the relationship between the severity of diﬀerent psy-
chophysical strain and blood levels of cytokines, chemokines and
growth factors in healthy volunteers working at a hospital. To this aim,
we have taken beneﬁt of proteomic analysis using a multiplex im-
munoassay built on magnetic beads for the quantitation of multiple
analytes within a single assay (Zanin et al., 2012). Using this technique,
we assessed a panel of 48 chemokines, cytokines and growth factors,
aiming to test the hypothesis that serum concentrations of pro-in-
ﬂammatory cytokines and growth factors are upregulated, and immune
defense related chemokines and growth factors are decreased in rela-
tion to prolonged psychosocial stress (Segerstrom and Miller, 2004). In
addition, we measured the neurotrophin BDNF with an ELISA assay,
which we recently validated to be the most reliable among six com-
mercial assays (Polacchini et al., 2015), and we hypothesized that it
could be decreased in relation to chronic work-related stress.
2. Material and methods
2.1. Participants
The study, conducted as part of larger project aimed at assessing
work-related stress risk, was performed examining a sample of workers
in an Italian healthcare organization. Workers were informed before-
hand by management and participated voluntarily to the study.
Workers completed a self-report questionnaire aimed at determining
psychophysical strain. Before the questionnaire was administered, the
purpose of the present study was explained by a member of the research
team, who emphasized that participants should report only psycho-
physical symptoms attributable to work-related stressful situations (i.e.,
not imputable to other stressful life events, such as, for example, pro-
viding care for a family member or ﬁnancial diﬃculties). The ques-
tionnaire was completed by 115 subjects who agreed to participate to a
clinical interview followed by a blood sample withdrawal. Then, blood
samples were collected and sera isolated as previously described
(Polacchini et al., 2015). Subjects reporting mood and anxiety dis-
orders, neuroendocrine diseases, non-pharmaceutical drug abuse or
dependence, according to DSM-IV-TR criteria, were excluded from the
enrollment. Therefore, the study sample comprised 115 workers, of
which 71.3% were women. Regarding the work position, 16.7% were
managers-doctors, 63.3% were doctors or head nurses, 20% were
nurses. Most respondents had a permanent contract (95.9%) and were
working in the hospital for more than 8 years. All participants gave
their written, informed consent, and the study was approved by the
local ethics committee according to the recommendations of the De-
claration of Helsinki.
2.2. Work-related stress assessment
Subjects were assessed for psychophysical strain using ﬁve scales
taken from the Q-BO test, an instrument standardized for the Italian
context (De Carlo et al., 2008; Falco et al., 2012). The ﬁrst part of the
questionnaire asked respondents to indicate how often, over the past six
months, the psychophysical symptoms (see list below) attributable to
work-related stressful events, had appeared or exacerbated. The six
psychophysical strain dimensions assessed were: anxiety, emotion
(depression-like), gastrointestinal disturbances, cardiac disturbances,
ergonomic dysfunction at the workplace. The six point response scale
ranged from 1 (never) to 6 (every day). The overall strain score was
estimated by averaging the scores of each subscale. Both the self-report
version of the questionnaire (the one adopted in this study, see Triﬁletti
et al., 2013) and the form developed for the administration by the oc-
cupational physician (Falco et al., 2013b) showed good psychometric
properties. Additionally, Cronbach's alpha in the present study was 0.80
for the anxiety subscale, 0.80 for emotion (depression-like) symptoms,
0.78 for gastrointestinal disturbances, 0.66 for the cardiac disturbances,
and 0.80 for ergonomic dysfunction.
The Q-Bo test consists of various scales, reformulated and reduced
in the most recent release to about 200 items (from 350 of the original
version) - thanks to an experiment conducted on over 30,000 workers -
and with a delivery time of about 1 h. The protocol can be adapted to
the diﬀerent needs of organizations in the various public and private
contexts both for modules and for speciﬁc constructs as well as social
and personal information. In particular, sets of scales integrated with
each other are available in function of the diﬀerent types and sizes of
the organizations object of survey. The main test conﬁgurations are
directed speciﬁcally to those areas: Education/Training,
Manufacturing, metal working industries, Public Administrations and
Public Services, Health Sector, Financial Services/Insurance, Social
Services. For the diﬀerent sectors, in a benchmarking perspective,
speciﬁc reference samples are available (normative values). The scales
were developed based on the most extensive international literature, on
the needs created by the Italian legislation and the requirements of
European and global organizations working in the ﬁeld of health and
safety at work. Thanks to the adoption of a systemic approach, the
multidimensional model is used to detect a broad spectrum of work,
organizational and individual factors representing potential sources of
risk. In particular, by means of the proposed dimensions, the model
aims at assessing behavioural, physiological and psychological stress/
strain (with particular reference to burnout). These dimensions are in
fact designed in order to take into account factors, such as the quanti-
tative and cognitive workload, the degree of control/autonomy, the
social rewards in terms of support from the organization, the profes-
sional growth, the organizational equity and justice, and the various
forms of conﬂict including conﬂicts work/life, person-role, with col-
leagues, between groups/departments of the same organization, with
superiors and co-workers, changes, no clear deﬁnition of responsi-
bilities. These elements can have negative consequences for the health
of the worker and can cause at the same time a deterioration of cor-
porate performance. Another section of the test is dedicated to the
detection of psychological and physical symptoms (such as irritability,
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depression, feelings of ineﬀectiveness, gastrointestinal problems, in-
somnia, cardiac arrhythmia) and behavioural symptoms (such as abuse
of alcohol, drugs, smoking) and any other discomfort, symptoms and
diseases that can be associated with the risk of work-related stress and
therefore constitute additional sources/consequences of the risk. The
scales taken from the Qu-Bo test assess symptoms that are known to be
stress-related on an epidemiological basis (see for example Nixon et al.,
2011). Moreover, several standardized self-reported questionnaires in
the literature assess similar symptoms or dimensions/subscales (e.g.,
the Physical Symptoms Inventory, Spector and Jex, 1998; the Physical
Health Questionnaire, Schat et al., 2005). With respect to gastro-
intestinal and cardiac symptoms, examples of item are “Stomach/ab-
domen cramps or pain” and “heart pounding without any apparent
reason”, respectively.
The Q-Bo test also investigates some individual characteristics and
resources such as resilience, optimism, sense of eﬃcacy, coping strategy
(i.e. mode of behaviour to cope with the diﬃculties), negative aﬀec-
tivity, tendency to over-commitment and social desirability, in order to
assess the validity and reliability of answers to several questions. The
test also evaluates the critical variables for the organization such as
security measures, air conditioning, lighting, cleanliness and hygiene,
pleasantness of the working place.
2.3. Biochemical assessments
Blood samples were collected in a resting and fasting state between
9.00 am and 12.00 pm in anticoagulant-free tubes and let them to clot
for 1 h at room temperature, then resting for an additional hour of at
4 °C. Serum was collected by centrifugation at 2000× g for 10min at
4 °C, aliquot and stored at−80 °C until assayed. Multiple analytes were
assessed, as listed in Table 1. Serum BDNF levels were as previously
described (Polacchini et al., 2015), using the BDNF Rapid™ ELISA kit
(Biosensis), based on sandwich technology. Cytokines, chemokines and
growth factors were measured taking advantage of the multiplex ELISA
technology, employing the Bio-Plex Pro Human xMAP Assay 21-plex
and 27-plex (Bio-Rad Laboratories Srl, Milan, Italy) read on a Bio-Plex
200 instrument, according to manufacturer's instructions. Reliability of
cytokines measurements with this methodology was previously vali-
dated (Zanin et al., 2012). All samples were assayed in duplicate in
adjacent wells.
2.4. Statistical analyses
To test for possible diﬀerences in age and body-mass index (BMI)
distributions between female and male population considered in this
study, we used the t-test for independent samples. To test sex diﬀer-
ences in distribution of psychophysical strain scores we used a Mann-
Whitney U test. In addition, to verify the possible confounding eﬀect of
BMI, we performed a partial correlation analysis with the scores of
psychophysical strain, after controlling for gender. When biochemical
variables had sample values below the lower limit of detection (Out-Of-
Range values or OOR); when OOR values were over the 30% of the total
sample, the analytes were excluded. When performing univariate ana-
lysis, for remaining OOR values we imputed the half of the declared
sensitivity value for each analyte, while for Partial Least Square re-
gression analysis all variables having OOR were excluded in order to
avoid any distortion in the normalized distribution. The inﬂuence of the
use of drugs on biochemical variables values was tested performing a
Mann-Whitney U test. Normality distributions of the independent
variables were assessed by Shapiro-Wilks tests and visually inspected by
Quantile-Quantile (Q-Q) plot analyses (not shown). Since most of the
biochemical variables were not normally distributed we applied log-
transformation in order to approximate normality distributions, thus
being able to perform both univariate associations and multivariate
analysis, with the aim to investigate correlations between biochemical
variations and diﬀerences in the scores of psychophysical strain. As
univariate analyses, we perform partial correlation analyses controlling
for gender and BMI to identify association between dependent variables
(psychophysical strain scores) and each independent variable (bio-
chemical markers). Since we performed multiple factors assessment on
same samples, we chose to not correct for multiple comparisons across
the diﬀerent analytes, because this would enhance the probability of
type II errors (Janelidze et al., 2013). A multivariate analysis was also
carried out to take in account for potential correlations within the in-
dependent variables. Thus, we performed Partial-Least Square dis-
criminant analysis (PLS) and Variable Importance to the Projection
(VIP) scores were estimated, for each independent variable, as the
average over three latent factors extracted. VIP scores are estimate of
the importance of each variable to the model and values equal to or
greater than one can be considered prominent in the given model.
3. Results
3.1. Demographic variables
We investigated a possible relationship between the serum levels of
cytokines and chemokines, BDNF and other growth factors (listed in
Table 1), with the scores of psychophysical strain in 115 healthcare
assistants matching the inclusion criteria for this study. Demographic
values (age and BMI) are given in Table 2. Of note, BMI scores in female
were signiﬁcantly lower than those in male population (t-test,
t =−4.53, p < 0.001). Psychophysical strain was assessed using ﬁve
subscales, namely anxiety, emotion (depression-like), gastrointestinal
disturbances, cardiac disturbances, ergonomic dysfunction at the
workplace and by an overall psychophysical strain score, deﬁned as the
average of the ﬁve subscales (Table 3). In the initial section of the
Table 1
List of biochemical variables.
Cytokines Chemokines Growth factors
21-plex (BioRad) IL-1α; IL-2Rα; IL-3; IL-12 (p40); IL-16; IL-18; IFN-α2;
LIF; MIF; SCF; TNF-β; TNFSF10/TRAIL




27-plex (BioRad) IL-1β; IL-1Ra; IL-2; IL-4; IL-5; IL-6; IL-9; IL-10; IL-12
(p70); IL-13; IL-15; IL-17; IFN-γ; TNF-α; CSF2/GM-CSF
CXCL8/IL-8; CCL11/Eotaxin; CCL2/MCP-1; CXCL10/
IP-10; CCL3/MIP-1α; CCL4/MIP-1β; CCL5/RANTES;
IL-7; basic FGF;
CSF3/G-CSF; PDGF-BB; VEGF
BDNF RapidTM ELISA kit
(Biosensis)
/ / BDNF
Biochemical analytes listed by cytokines, chemokines and growth factors. IL= interleukin; LIF= leukemia inhibitory factor; MIF=macrophage migration inhibitory factor; SCF= stem
cell factor; TNF= tumor necrosis factor; TNFSF= tumor necrosis factor superfamily member; TRAIL=TNF-related apoptosis-inducing ligand; IFN= interferon; CSF= colony stimu-
lating factor; GM-CSF= granulocyte macrophage colony stimulating factor; CCL= chemokine C-C motif ligand; CTACK=cutaneous T-cell-attracting chemokine; CXCL= chemokine C-
X-C motif ligand; GRO=melanoma growth stimulating activity; MCP=monocyte chemoattractant protein; MIG=monokine induced by gamma interferon; SDF= stromal cell-derived
factor; Eotaxin= eosinophil chemotactic protein; IP= interferon gamma-induced protein; MIP=macrophage inﬂammatory protein; RANTES= regulated on activation, normal T cell
expressed and secreted; HGF=hepatocyte growth factor; M-CSF=macrophage colony-stimulating factor; NGF=nerve growth factor; CLEC11=C-type lectin domain family 11;
SCGF= stem cell growth factor; FGF= ﬁbroblast growth factor; G-CSF= granulocyte-colony stimulating factor; PDGF-BB= Platelet-derived growth factor subunit B; VEGF= vascular
endothelial growth factor; BDNF=brain-derived neurotrophic factor.
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questionnaire respondents were asked to indicate how often, over the
past six months, the psychophysical symptoms (see list above) attri-
butable to work-related stressful events, had appeared or exacerbated
and to discriminate job versus other non-work related stressors. The
ﬁrst step was to verify if the demographic variables (gender, BMI and
age) could account for distribution diﬀerences of the scores among the
diﬀerent dimensions of psychophysical strain. Indeed, performing a
non-parametric Mann-Whitney U–test to assess diﬀerences in scores
distribution between gender, we found that female subjects had sig-
niﬁcantly higher score values than males for all the psychophysical
strain dimensions (Table 4). Regarding the possible confounding eﬀect
of BMI on psychophysical strain scores, after controlling for gender in a
partial correlation analysis, we found that it negatively correlates with
anxiety, gastrointestinal disturbance and the overall strain score in both
total (N= 115) and drug-free (N=89) sample populations (see
Supplementary Table S1). However, since age did not correlate with
any of the psychophysical strain score, even after controlling for gender
or BMI (not shown), it was not considered as a possible confounder. For
all subsequent analysis we performed corrections for gender and BMI.
3.2. Biochemical variables
The pre-analytical stages, consisting in serum samples collection
and storage, were performed as described previously (Polacchini et al.,
2015). For the analytical stage, taking advantage of the multiplex
technology, we screened 48 analytes among cytokines, chemokines and
growth factors; BDNF was assessed using the Biosensis kit, which ex-
ploits a classical sandwich ELISA technology (see Table 1, Materials and
Methods). The following analytes (11) were excluded from the dataset
because more than 30% of samples were below the lower limit of de-
tection (Out-Of-Range or OOR values): interleukins 2, 15, 1-α, 3, 12p40
(IL-2, IL-15, IL-1α, IL-3, IL-12p40), interferon α2 (IFN-α2), leukemia
inhibitory factor (LIF), chemokine C-C motif ligand 7 (CCL7/MCP-3),
colony stimulating factor 1 (CSF1/M-CSF), beta nerve-growth factor (β-
NGF) and tumor necrosis factor-β (TNF-β). Except for cases showing
value below the limit of detection (OOR cases), none of the other cases
show signiﬁcant upward outliers: log transformed, standardized values
(centered on mean) were all below three standard deviations. The
distribution values of the remaining analytes (38) are listed in
Supplementary Tables S3 and S4. Because 26 persons out of 115 were
using pharmaceutical drugs, we veriﬁed if drug assumption had an
impact on the analyte levels. Drugs taken by subjects are the most
common in Western-country population, speciﬁcally: anti-hyperten-
sive/heart protectors (42%), anti-lipemic (32%), thyroid stimulators
(levotiroxin, 21%), non-steroid anti-inﬂammatory drugs (16%), anti-
migraine (11%) – the sum is not 100% because some subjects are taking
more than one drug. We tested their eﬀects on cytokines levels com-
paring the median values between the two populations of drug takers
and non-takers. As a result, 21 analytes showed signiﬁcantly diﬀerent
levels between cases who used drugs and who did not (Mann-Whitney U
test; see Supplementary Table S2). In general, pharmaceutical drugs
had a negative inﬂuence on analytes level, with the exception of in-
terferon-γ (INF-γ) and chemokines C-C motif ligand 4 and 5 (CCL4/MIP-
1β and RANTES, respectively), for which we observed increased
median values in drug users.
There was no diﬀerence in gender distribution among pharmaceu-
tical drug users (Female/Male, 17/9, χ2= 2.46, P= 0.117) and there
was also no signiﬁcant diﬀerence between the scores of psychophysical
strain in subjects who use drugs and who do not (Mann-Whitney U test;
not shown). Given these results, in order to limit this confounder and
increase the power of predictors, we decided to exclude all the 26
subjects who used drugs. Distributions of psychophysical strain scores
of the remaining 89 cases were basically equal to the previous ones
(Tables 3 and 4 and S1). After that, since most of the biological vari-
ables were not normally distributed, we log transformed all in-
dependent variables (including BMI), attempting to achieve normal
distribution. Shapiro-Wilks test for normality not always gave non-
signiﬁcant results, but Q-Q plot analysis displays a good approximation
to normal distribution (not shown). The following correlation analyses
were performed also on non-transformed data (not shown) giving si-
milar results, leading us to use the transformed data in order to perform
multivariate analysis as well.
3.3. Univariate analysis
As univariate analysis, we performed partial correlations using the
log-transformed biochemical data, controlling for gender and BMI, in
order to detect association between each predictors (29 in total) and the
dimensions of psychophysical strain. Signiﬁcant associations were
Table 2
Demographics of the whole sample population (N=115).
N Mean SD Min/Max P
Age, years Female 82 44.90 8.34 25/60 0.830
Male 33 45.30 10.52 25/61
BMI, kg/m2 Female 81 22.99 2.79 17.72/33.46 < 0.001
Male 33 25.67 3.46 17.63/33.56
N Mean SD Min/Max P
Age, years Female 65 43.82 8.28 25/60 0.508
Male 24 42.42 10.16 25/61
BMI, kg/m2 Female 64 22.86 2.89 17.72/33.46 0.005
Male 24 24.90 3.10 17.63/30.32
Age and BMI distributions split by gender. Number of subjects (N), average values
(mean), standard deviations (SD) and minimum and maximum values (min/max) are
given, along with P values (P) as the result of distribution comparison between male and
female, for both age and BMI. Upper table displays whole population (N=115); lower
table the drug-free sample population (N=89).
Table 3
Psychosocial strain scores distribution in the whole (N=115) and drug-free (N=89) sample population.
Anxiety Emotion Gastric Cardiac Ergonomics Overall strain
N total population 115 115 115 115 115 115
Mean/SD 2.41/1.04 1.77/0.80 2.07/1.01 1.58/0.85 2.59/1.13 2.08/0.81
Min/Max 1.00/5.40 1.00/5.00 1.00/6.00 1.00/5.00 1.00/5.40 1.00/5.16
Anxiety Emotion Gastric Cardiac Ergonomics Overall strain
N Valid (Missing) 89 (33) 89 (33) 89 (33) 89 (33) 89 (33) 89 (33)
Mean/SD 2.38/1.02 1.79/0.83 2.01/1.06 1.55/0.84 2.65/1.14 2.10/0.82
Min/Max 1.00/5.40 1.00/5.00 1.00/6.00 1.00/5.00 1.00/5.40 1.00/5.16
Scores distribution of psychophysical strain in the whole sample population (N=115) and after exclusion of pharmaceutical drug users and subjects missing strain scores (N=89).
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found for a total of seven of the independent variables. Speciﬁcally, for
anxiety the chemokines C-C motif ligand 2, 5, 11 and 27 (CCL2/MCP-1,
CCL5/RANTES, CCL11/Eotaxin, CTACK/CCL27) show a negative
Pearson's product moment of respectively −0.342, −0.320, −0.304
and −0.301 and the interleukin 6 (IL-6) of −0.223. Similarly, for the
gastric disturbance, the partial correlation of CCL2/MCP-1, CCL11/
Eotaxin and CTACK/CCL27 was negative and with a Pearson's product
moment of respectively −0.214, −0.325, −0.235, while for inter-
leukin 17 (IL-17) the association was positive (0.280). For the cardiac
item, only the chemokine CTACK/CCL27 was negatively associated
(−0.272), while for ergonomics problem, a negative partial correlation
was found for CCL5/RANTES and CCL11/Eotaxin (−0.221 and−0.240
respectively) and intriguingly, a positive correlation with BDNF
(0.284). For the overall strain, results were similar to those found for
the anxiety dimension. In fact, it showed a partial negative correlation
with CCL2/MCP-1, CCL5/RANTES, CCL11/Eotaxin, CTACK/CCL27,
with a Pearson's product moment of respectively −0.263, −0.274,
−0.307 and −0.258, but no association with IL-6. All α errors were
below 0.05 as reported in detail in Table 5; for a graphical re-
presentation of the partial correlations see Fig. 1. No association with
any of the predictors was found for the Depression-like subscale. To
evaluate the chance that multiple comparisons could increase type I
errors, we performed correction of the p-value according to the Ben-
jamini-Hochberg (BH) procedure which estimates the false-discovery
rate (FDR) based on ranked ascending p-values. Correction was done on
the number of test performed n = 38, according to the formula pj = n/
j*pj, where p is the ranked p-value and j is its percentile rank (Noble,
2009). Only CCL2/MCP-1 retains a signiﬁcant association with anxiety.
However, when considering n=7, factors associated with anxiety,
gastric and overall strain (indicated as stress) subitems were signiﬁcant.
Corrected p-values are given in Supplementary Table S5.
Finally, to determine the contribution of each of the identiﬁed
markers to the diﬀerent pshychophysical strain subscales, we analyzed
the eﬀect size for the calculated correlation factor r, reported as abso-
lute value. On the basis of the Cohen's d values, we found a medium
eﬀect size for CCL2/MCP-1, CCL5/RANTES, CCL11/Eotaxin, and
CCL27/CTACK on anxiety, for CCL11/Eotaxin on gastric problems and
stress in general (overall strain), while the eﬀect of the other factors
was small (Supplementary Table S6).
3.4. Multivariate analysis
Multivariate analysis was also performed to explore association
between predictors. More speciﬁcally, the partial least square regres-
sion procedure (PLS) was identiﬁed as the best suited method for this
purpose because it is particularly useful when predictor variables are
highly correlated or the number of predictors is considerable in respect
to the number of cases. This method extracts, at ﬁrst, several latent
factors that explain as much of the covariance as possible between
dependent and independent variables and then computes a series of
score (Variable Importance to the Projection or VIP) that help to
identify predictors that best contribute to the association with the de-
pendent variable. As done before with partial correlation analysis, for
PLS we used each subscale of psychophysical strain as dependent
variable and cytokines, chemokines, growth factors and the interaction
eﬀect between gender and BMI as independent variables. In this ana-
lysis, we further eliminated the variables whose OOR were substituted
with ﬁxed values and therefore could introduce a bias in the distribu-
tion: interleukins 1β, 5, 16, 2 receptor-α (IL-1β, IL-5, IL-16, IL-2Rα,
respectively), colony stimulating factor 2 (CSF2/GM-CSF), stem cell
factor (SCF), chemokines C-X-C motif ligand 1 and 12 (CXCL1/GRO-α
and CXCL12/SDF-1α), and tumor necrosis factor super-family member
10 (TNFSF10/TRAIL). In addition, these variables did not correlate
with any of the pshychophysical strain subscales in the univariate
analysis. The graphs in Fig. 2 show the contribution of information
(VIP) of each variable to anxiety, gastric and cardiac disturbances,
Table 4
Gender diﬀerence in psychophysical strain scores in the whole (N=115) and drug-free (N=89) sample population.
Psychophysical strain total Anxiety Emotion Gastric Cardiac Ergonomics Overall strain
Female. N= 82; Mean rank 62.86 63.40 62.53 62.15 62.51 63.68
Male. N= 33; Mean rank 45.92 44.59 46.74 47.68 46.80 43.88
Z −2.47 −2.75 −2.31 −2.24 −2.29 −2.88
Asymp. Sig. P (2-tailed) 0.013 0.006 0.021 0.025 0.022 0.004
Psychophysical strain valid Anxiety Emotion Gastric Cardiac Ergonomics Overall strain
Female. N= 65; Mean rank 46.73 48.06 47.17 46.58 46.17 47.24
Male. N= 24; Mean rank 40.31 36.71 39.13 40.71 41.83 38.94
Z −1.04 −1.85 −1.31 −1.02 −0.70 −1.35
Asymp. Sig. P (2-tailed) 0.296 0.065 0.190 0.310 0.481 0.179
Results of comparison (Mann-Whitney U test) between female and male scores of psychophysical strain in the total sample population (N=115) and after exclusion of pharmaceutical
drug users and subjects missing the strain scores (N=89). Sizes, (N), rank values, Z scores and asymptotic P values (Asymp. Sig. P, 2-tailed) are given. In bold are highlighted P < 0.05.
Table 5
Signiﬁcant correlation between strain scores and biochemical variables.
Variable ID Anxiety Gastric Cardiac Ergonomics Overall strain
CCL11/Eotaxin (df= 83) −0.304 (0.005) −0.325 (0.002) −0.240 (0.027) −0.307 (0.004)
CCL27/CTACK (df= 84) −0.301 (0.005) −0.235 (0.029) −0.272 (0.011) −0.258 (0.017)
CCL2/MCP-1 (df= 83) −0.342 (0.001) −0.214 (0.049) −0.263 (0.015)
CCL5/RANTES (df= 83) −0.320 (0.003) −0.221 (0.042) −0.274 (0.011)
BDNF (df= 82) 0.284 (0.009)
IL-17 (df= 83) 0.280 (0.010)
IL-6 (df= 83) −0.223 (0.040)
Summary of the signiﬁcant results from partial correlation analysis, controlling for gender and BMI, between biological variables (independent variables, ﬁrst column) and scores of
psychophysical strain (ﬁrst row). Correlation values (minus sign indicate a negative correlation) and P values in brackets, highlighted in bold, are given. CCL= chemokine C-C motif
ligand; CTACK= cutaneous T-cell-attracting chemokine; MCP=monocyte chemoattractant protein; RANTES= regulated on activation, normal T cell expressed and secreted;
BDNF=brain-derived neurotrophic factor; IL= interleukin.
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ergonomic problems and overall strain. Results essentially replicated
the ﬁndings obtained with the partial correlation analysis, in which the
chemokines CCL2/MCP-1, CCL5/RANTES, CCL27/CTACK, CCL11/Eo-
taxin, the interleukin IL-6 and IL-17 and the neurotrophin BDNF are the
best contributors, since their score is above one. Interestingly, other
analytes that were not identiﬁed in the partial correlation analysis,
showed up with PLS: interleukin 9 (IL-9) for anxiety and cardiac pro-
blems, interleukin 18 (IL-18) for ergonomic problems and overall stress
and chemokine C-C motif ligand 4 (CCL4/MIP-1β) for gastric problem
and overall strain. In contrast, IL-6 resulted weakly associated with
anxiety score as well as with the other strain dimensions. Taken to-
gether, these results pointed out a clear connection between some
elements of the chemokine pattern and the features of psychophysical
strain. Interestingly, BDNF was positively associates with the score of
the ergonomic problems at the workplace.
4. Discussion
In this study, we investigated the relationship between the scores
obtained from self-assessed questionnaires for the stress-risk evaluation
(subjective assessments) and changes in circulating level of humoral
mediators (objective measures). Serum levels of 48 chemokines, cyto-
kines and growth factors were measured using a multiplex im-
munoassay, and serum brain-derived neurotrophic factor (BDNF) by
ELISA. The perceived stress at work was estimated in 115 healthy
hospital workers, using an instrument standardized for the Italian
context, the Qu-BO test (De Carlo et al., 2008; Falco et al., 2012): ﬁve
subscales were administered that evaluate pshychophysical strain in
term of anxiety, emotional status, gastrointestinal and cardiac dis-
turbances, along with ergonomic problems at the workplace (headache,
hurting neck or shoulders or back pain). Higher anxiety scale scores
Fig. 1. Scatter plots showing correlations between the given chemokines (CCL2/MCP-1, CCL11/Eotaxin, CCL27/CTACK, CCL5/RANTES), cytokines (IL-6, IL-17) and growth factor
(BDNF) and the items of psychophysical strain. Regression lines, R square and P values are displayed. CCL= chemokine C-C motif ligand; CTACK= cutaneous T-cell-attracting che-
mokine; MCP=monocyte chemoattractant protein; RANTES= regulated on activation, normal T cell expressed and secreted; BDNF=brain-derived neurotrophic factor;
IL= interleukin.
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were correlated with lower serum chemokine C-C motif ligand-2
(CCL2/MCP-1), chemokine C-C motif ligand-5 (CCL5/RANTES), che-
mokine C-C motif ligand-27 (CCL27/CTACK), chemokine C-C motif li-
gand-11 (CCL11/Eotaxin) and interleukin-6 (IL-6); gastrointestinal
disturbances correlated with increased levels of interleukin-17 (IL-17)
and reduced CCL11/Eotaxin, CCL27/CTACK and CCL2/MCP-1; while
cardiac dysfunctions associate only to reduced CCL27/CTACK, and er-
gonomic dysfunction correlated with increased BDNF and reduced
CCL11/Eotaxin and CCL5/RANTES. We propose that these 7 serum
factors may provide a distinct signature for each diﬀerent stress-related
psychophysical outcome giving indications on individual vulner-
abilities.
Our results highlighted a signiﬁcant gender diﬀerence in the per-
ceived job-stress. This is not surprisingly, since males and females are
known to diﬀerently respond to stress, both acute and chronic
(McEwen, 2012; McEwen et al., 2015). In particular, we found that
women had higher scores for all the subscales of psychophysical strain.
The ﬁnding that women are more susceptible to job-related psychoso-
cial stress is in line with previous evidence showing a higher tendency
for female to develop stress-related pathology such as anxiety and de-
pression (Altemus et al., 2014). This condition is potentially due to an
estrogen-driven delayed shut oﬀ of the HPA axis (Goel et al., 2014).
The Qu-Bo Test is a self-report instrument aimed at determining
perceived characteristics of the work environment (i.e., job stressors)
that may elicit a stress response in the individual. Similarly, the Qu-Bo
Test assesses perceived psychological and physical symptoms due to
work-related stress (i.e., psychophysical strain). Other instruments,
such as the V.I.S. method (see for example Falco et al., 2013b), in-
vestigate observer ratings (e.g., supervisor's rating) of job stressors, as
well as physician's rating of psychophysical strain. Accordingly, the aim
of this study was to investigate the association between “perceived”
psychophysical strain and serum levels of possible biomarkers of work-
related stress. Therefore, it is possible that female workers face higher
levels of job stressors (e.g., work-family conﬂict) and, consequently,
they experience higher levels of psychophysical strain, as we observed
in this study.
Concerning BMI, we observed a negative correlation with psycho-
physical strain, signiﬁcant for anxiety, gastric problems and overall
strain, therefore, all subsequent analysis for associations with bio-
chemical variables were conducted controlling for both gender and
BMI.
After controlling for BMI and gender, we found that higher scores of
each psychophysical strain subscale were associated with lower serum
concentration of some member of the chemokine family, in particular
Fig. 2. Variable Importance to the Projection (VIP) ranking biological markers for their
contribution to the association to psychophysical strain, assessed by Partial Least Square
(PLS) discriminant analysis. Analytes with VIP values equal or above one (dashed line as
reference) are the best contributors to a given model. IL= interleukin; LIF= leukemia
inhibitory factor; MIF=macrophage migration inhibitory factor; SCF= stem cell factor;
TNF= tumor necrosis factor; TNFSF= tumor necrosis factor superfamily member;
TRAIL=TNF-related apoptosis-inducing ligand; IFN= interferon; CSF= colony stimu-
lating factor; GM-CSF= granulocyte macrophage colony stimulating factor;
CCL= chemokine C-C motif ligand; CTACK=cutaneous T-cell-attracting chemokine;
CXCL= chemokine C-X-C motif ligand; GRO=melanoma growth stimulating activity;
MCP=monocyte chemoattractant protein; MIG=monokine induced by gamma inter-
feron; SDF= stromal cell-derived factor; Eotaxin= eosinophil chemotactic protein;
IP= interferon gamma-induced protein; MIP=macrophage inﬂammatory protein;
RANTES= regulated on activation, normal T cell expressed and secreted;
HGF=hepatocyte growth factor; M-CSF=macrophage colony-stimulating factor;
NGF=nerve growth factor; CLEC11=C-type lectin domain family 11; SCGF= stem cell
growth factor; FGF= ﬁbroblast growth factor; G-CSF=granulocyte-colony stimulating
factor; PDGF-BB= Platelet-derived growth factor subunit B; VEGF= vascular endothelial
growth factor; BDNF=brain-derived neurotrophic factor.
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CCL2/MCP-1, CCL5/RANTES, CCL27/CTACK and CCL11/Eotaxin.
Since these chemokines are involved in immune cells migration and
communication, our ﬁndings support the hypothesis that chronic stress
induces suppression of both cellular and humoral response (Segerstrom
and Miller, 2004). Interestingly, a previous study on German industrial
workers showed that higher scores of eﬀort-reward imbalance (Siegrist
et al., 2004) predict lower bone-marrow derived progenitor cells
(Fischer et al., 2009). Other authors suggested an increased pro-in-
ﬂammatory state in job-related chronic stress (Asberg et al., 2009;
Bellingrath et al., 2010). As an example, healthy school teachers with
high eﬀort–reward-imbalance and over-commitment show increased
production of IL-6 and TNF-α cytokines, which are mainly classiﬁed as
pro-inﬂammatory (Bellingrath et al., 2010). Signiﬁcantly, they also
found in agreement with our results, dampened innate immune defense
in term of reduction in natural-killer (NK) cells, which are important
players of the humoral immunity (Bellingrath et al., 2010). Chemokine
C-C motif ligand 2 (CCL2/MCP-1), one of the best characterized che-
mokines, is able to attract monocytes and basophils but not neutrophils
or eosinophils. CCL2/MCP-1 has been categorized mainly as pro-in-
ﬂammatory and implicated in diﬀerent stress-related pathologies
characterized by monocytic inﬁltrates, like psoriasis, rheumatoid ar-
thritis or atherosclerosis (Amasyali et al., 2009). However, it augments
monocyte anti-tumor activity and can exert also anti-inﬂammatory ef-
fects (Deshmane et al., 2009). Our observation of reduced circulating
CCL2/MCP-1 associated to anxiety and gastric problems, is apparently
in contrast with a previous study on psychosocial stress in women re-
porting increased levels of CCL2/MCP-1, vascular endothelial growth
factor (VEGF) and epidermal growth factor (EGF) in stressed workers
(Asberg et al., 2009). However, the study included a heterogeneous
group of long-term sick-leave subjects diagnosed for any aﬀective or
stress-related mental disorder (depression, anxiety disorder, stress dis-
order, burnout syndrome, exhaustion disorder). Of note, CCL2/MCP-1,
as well as other chemokines, can be produced centrally by microglia
and astrocytes, and also neurons, and plays important roles in both
physiological and pathological brain conditions. CCL2/MCP-1 can
compromise the blood-brain-barrier integrity (Yao and Tsirka, 2014),
but it also has neuroprotective eﬀects (Chiu et al., 2010).
We observed negative associations between CCL27/CTACK and the
scores of anxiety, gastric and cardiac problems as well as overall strain
dimension. Chemokine C-C motif ligand 27 (CCL27/CTACK) is a che-
motactic factor mediating the homing of lymphocytes to cutaneous
sites. Interestingly, high anxious mice showed lowered CCL27/CTACK,
associated with an increased skin cancer burden (Dhabhar et al., 2012).
We also found negative associations between the scores of anxiety and
ergonomic problems at the workplace and the chemokines CCL5/
RANTES and CCL11/Eotaxin. Lower chemokine levels, including CCL2/
MCP-1 and CCL11/Eotaxin, were found in cerebrospinal ﬂuid (CSF) of
suicide attempters respect to healthy controls (Janelidze et al., 2013),
and increased CCL5/RANTES was found in schizophrenic patients but
not in major-depressive subjects (Domenici et al., 2010). Both CCL27/
CTACK and CCL5/RANTES are considered mainly pro-inﬂammatory
chemokines and are involved in the recruitment and function of eosi-
nophils. However, at the moment, the literature concerning job-related
stress is not suﬃcient to support or disprove our ﬁndings.
Concerning the correlation between interleukins and psychophy-
sical strain, previous studies showed that chronic stress is associated
with increased circulating levels of pro-inﬂammatory cytokines IL1b,
IL-6, INF-γ and TNF-α (Bellingrath et al., 2010; Hansel et al., 2010;
Hodes et al., 2016) but studies in work-related stress have reported
conﬂicting results. For example, Asberg and colleagues found no asso-
ciation between interleukins, INF-γ, TNF-α and psychosocial stress in
women (Asberg et al., 2009). Here, we found a partial negative corre-
lation between IL-6 and anxiety scores. IL-6 acts locally to promote
migration of leukocytes from the blood stream to the site of infection,
but also centrally, promoting fever, appetite suppression and stimula-
tion of HPA axis. IL-6 has a recognized activity of both promoting and
inhibiting inﬂammation (Scheller et al., 2011). A study on a large adult
cohort found that persons with a current anxiety disorder, in particular
women suﬀering of social phobia, had lower levels of IL-6 (Vogelzangs
et al., 2013). Interestingly, although IL-6 is predominantly classiﬁed as
a pro-inﬂammatory cytokine, it can also trigger anti-inﬂammatory
properties through the so-called ‘classical IL-6 signaling’ occurring on a
subset of T cells, hepatocytes, megakaryocytes, neutrophils and
monocytes through activation of the IL-6 receptor and the gp130 signal
transducer (Hodes et al., 2016). Thus, a reduction in classical IL-6
signaling may be involved in reduced immune response, in agreement
with our ﬁndings for chemokines.
Intriguingly, we found increased interleukin 17 (IL-17) in subjects
reporting gastric problems. IL-17 is a feature cytokine of the T-helper
17, which are important players in the Th1/Th2 balance regulation and
have a role in autoimmunity disease. IL-17 is associated with tissue
damage in brain, joints, heart, lungs and intestines in experimental
models (Steinman, 2007). Alterations in Th17 function have been
suggested also for depressive disorders (Beurel et al., 2013; Schmidt
et al., 2010). Interestingly, in a model of chronic psychosocial stress,
stressed mice developed spontaneous colitis and gut inﬂammation and
the eﬀects were mediated by Th17 activity and increased IL-17 levels
(Schmidt et al., 2010).
In our previous study (Girardi et al., 2015) we reported that IL-12, a
pro-inﬂammatory cytokine implicated in cellular immunity, was posi-
tively associated with interpersonal conﬂict at work (ICW) while we did
not ﬁnd here a signiﬁcant association with psychosocial stress. Other
studies have previously found opposite results for IL-12 in rats, leaving
unresolved the issue of regulation of this interleukin in stress. Ac-
cording to transactional models of stress, the relationship between
stressors and chronic mental and physical strain is still mediated by
coping (Deary et al., 1996), so this leaves room for possible diﬀerent
results between studies. Of note, both this and our previous study are
cross-sectional, so it is diﬃcult to know whether the stressor comes
before the strain or vice versa and which are the corresponding levels of
the diﬀerent serum factors analyzed. Although, the results of IL-17
obtained here are quite in line with those of Girardi and colleagues, the
dimensions investigated in the two studies are quite diﬀerent, which
leaves room for diﬀerences in results obtained.
In this study, we observed a positive association between serum
BDNF and the score of ergonomic problems at workplace. A previous
study on Japanese subjects with job-related stress pointed out a re-
duction trend in circulating BDNF (Mitoma et al., 2008). Diﬀerently,
another study found that chronically perceived stress increases serum
BDNF levels (Feder et al., 2009). Of note, BDNF levels are highly dy-
namic in response to stress and also vary across diﬀerent brain regions
(Gray et al., 2013); for example, during chronic stress, increased BDNF
levels have been found in amygdala while reduction has been described
in prefrontal cortex and hippocampus (Davidson and McEwen, 2012).
Our ﬁndings are in agreement with a previous study showing that pa-
tients with chronic musculoskeletal pain associated with Myofascial
Pain Syndrome or Fibromyalgia presented increased serum BDNF levels
(Caumo et al., 2016). Intriguingly, in these patients, increased serum
BDNF levels correlated with higher motor cortex excitability, possibly
leading to a disinhibition in the activity of the motor cortex and the
descending pain inhibitory system (Caumo et al., 2016). Our results
represent a ﬁrst indication that a similar mechanism may operate also
in chronic job-related stress.
We ought to underline some intrinsic limitations of this study such
as: 1) the study design involved only one single time point, thus the
results may suﬀer for time course variations. 2) Scores of work-related
stress resulted to be positive skewed, meaning our study population
have mild to low chronic stress; therefore results need to be replicated
in a more stressed population. 3) The sample size was relatively small
compared to the number of serum factors considered, thus increasing
the possibility of over-ﬁtting problems. 4) We did not control for other
primary mediators such as metabolic indicators (blood pressure,
A. Polacchini et al. Neurobiology of Stress 8 (2018) 82–91
89
cholesterol) or urinary excretion of cortisol, adrenaline and nora-
drenaline, thus limiting the possibility to identify an allostatic load
index. 5) Lastly, we did not check for historical and socio-economical
statuses which are confounders that potentially inﬂuence the response
to stress; however, our population was relatively homogenous in that
sense, since was extracted from the same environment. In addition,
immune alterations are hard to predict given the enhancing versus
suppressive eﬀects of stress on immune function (Dhabhar, 2014). Re-
plications with larger samples, possibly on a longitudinal study ana-
lyzing the eﬀect of interventions to reduce stressing situations at work
may resolve these limitations. Nevertheless, we believe our study adds
some valuable insight in immune mediator changes occurring in con-
ditions of work-related chronic stress.
4.1. Conclusions
The seven serum factors CCL27/CTACK, CCL11/Eotaxin, CCL2/
MCP-1, CCL5/RANTES, IL-17, IL-6 and BDNF that we found associated
in a speciﬁc combination to the diﬀerent psychophysical outcomes in
work–related chronic stress, are new potential objective indicators to be
coupled with the subjective assessments of psychophysical strain. As
evidenced in this discussion, these seven factors are not part of a single
stress-related mechanism, but are rather associated to diﬀerent psy-
chological and physical outcomes of stress, and therefore are likely to
reﬂect diﬀerent pathological mechanisms. Our results suggest reduced
immune defence as a potential hallmark of mild job-related stress.
Moreover, given that the pathological response to chronic stressful
conditions is largely linked to individual characteristics, the possibility
to have a distinct signature for the diﬀerent stress-related psychophy-
sical outcomes may provide a valuable tool to identify individual vul-
nerabilities in diﬀerent body districts and prevent the development of
more severe diseases.
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